Yingpai Pharmaceutical-B (07630) was included as a constituent stock of the Hang Seng Composite Index

According to the Zhitong Finance App, Yingpai Pharmaceutical-B (07630) announced that it has been selected by Hang Seng Index Limited and will be included as a component stock in the Hang Seng Composite Index (Hang Seng Composite Index) with effect from September 7, 2026.

After being included as a constituent stock of the Hang Seng Composite Index, the Company's shares are expected to meet the criteria for inclusion in Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect transactions. Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect are channels for capital market investors in Hong Kong and mainland China to trade and invest in stocks.

The Company believes that its inclusion as a constituent stock in the Hang Seng Composite Index indicates the recognition of the company's industry position, operating performance and overall value in the international capital market. It is expected that this move will enhance the trading liquidity of stocks, expand and diversify the shareholder base, and contribute to the company's long-term continuous growth.